04554nam 22006615 450 991025394260332120200706035249.03-319-59165-710.1007/978-3-319-59165-0(CKB)3710000001631533(MiAaPQ)EBC4947027(DE-He213)978-3-319-59165-0(PPN)203852621(EXLCZ)99371000000163153320170812d2017 u| 0engurcnu||||||||rdacontentrdamediardacarrierSafety, Ethics and Regulations /edited by Phuc Van Pham, Achim Rosemann1st ed. 2017.Cham :Springer International Publishing :Imprint: Springer,2017.1 online resource (330 pages) illustrationsStem Cells in Clinical Applications,2365-41983-319-59164-9 Includes bibliographical references at the end of each chapters and index.Part  I. Safety -- Chapter 1: The safety of allogeneic stem cell transplantation -- Chapter 2: Induced Pluripotent Stem Cell Therapy and Safety Concerns in Age-related Chronic Neurodegenerative Diseases -- Chapter 3: IClinical safety and applications of stem cell gene therapy -- Chapter 4:  The safety of non-expanded multipotential stromal cell therapies -- Part  II: Ethics and Regulations -- Chapter 5: A Normative Case for the Patentability of Human Embryonic Stem Cell Technologies -- Chapter 6. Ethical Considerations in Stem Cell Research on Neurologic and Orthopedic Conditions -- Chapter 7. New Regulatory Pathways for Stem Cell-Based Therapies: Comparison and Critique of Potential Models -- Chapter 8: Travelling cells – Harmonised European Regualtion and the BAMI stem cell trial -- Chapter 9: Oversight and Evidence in Stem Cell Innovation: An Examination of International Guidelines -- Chapter 10: The regulation of clinical stem cell research in China -- Chapter 11: Gov erning Stem Cell Therapies in India -- Chapter 12: Patenting human embryonic stem cells in the European Union context: an updated analysis of a complex issue -- Chapter 13: The regulatory situation for clinical stem cell research in China -- Chapter 14: Contested Tissues: the donation of oocytes and embryos in the IVF-Stem Cell Interface in China -- Chapter 15: Challenges to international stem cell clinical trials in countries with diverging regulations.This invaluable resource discusses the saftey, ethics, and regulations of developing stem cell clinical applications. Each chapter is contributed by a preeminent scientist in the field and covers such topics as clinical safety of stem cell gene therapy, the patentability of hESC technologies, international guidelines, challenges to international stem cell clinical trials, worldwide regulations including in emerging markets like China and Taiwan. Saftey, Ethics, and Regulations and the other books in the Stem Cells in Clinical Applications series will be invaluable to scientists, researchers, advanced students and clinicians working in stem cells, regenerative medicine or tissue engineering.Stem Cells in Clinical Applications,2365-4198Stem cellsRegenerative medicineTissue engineeringMedical ethicsBioethicsStem Cellshttps://scigraph.springernature.com/ontologies/product-market-codes/L16010Regenerative Medicine/Tissue Engineeringhttps://scigraph.springernature.com/ontologies/product-market-codes/L16080Theory of Medicine/Bioethicshttps://scigraph.springernature.com/ontologies/product-market-codes/H66000Bioethicshttps://scigraph.springernature.com/ontologies/product-market-codes/E14010Stem cells.Regenerative medicine.Tissue engineering.Medical ethics.Bioethics.Stem Cells.Regenerative Medicine/Tissue Engineering.Theory of Medicine/Bioethics.Bioethics.571.6Pham Phuc Vanedthttp://id.loc.gov/vocabulary/relators/edtRosemann Achimedthttp://id.loc.gov/vocabulary/relators/edtMiAaPQMiAaPQMiAaPQBOOK9910253942603321Safety, Ethics and Regulations1954757UNINA